AMRX•globenewswire•
Amneal to Report Fourth Quarter and Full Year 2025 Results on February 27, 2026
Summary
BRIDGEWATER, N.J., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), today announced that the Company will release its fourth quarter and full year 2025 financial results on Friday, February 27, 2026, prior to market open. The Company will host an audio webcast at 8:30 a.m. ET.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 27, 2026 by globenewswire